Tag: New leukemia drug is more effective and easier to use

New leukemia drug is more effective and easier to use

January 14, 2019

A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL). The drug, ibrutinib, attacks cancer cells without damaging normal cells, thus causing fewer side effects. The drug is taken as a pill once […]

Continue Reading